Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib. [PDF]
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Balaseviciute U +17 more
europepmc +2 more sources
[Nested variant of urothelial carcinoma complicated with pulmonary lymphangitis carcinomatosis. Case report]. [PDF]
Pale-González GA, Díaz-Fuentes H.
europepmc +1 more source
[Metabolic Dysfunction-Associated Steatotic Liver Disease and its association with prediabetes in adolescents with obesity]. [PDF]
Peralta-Cortázar C +8 more
europepmc +1 more source
Feasibility study of a behavioral lifestyle intervention for Hispanic/Latino patients with metabolic dysfunction-associated steatotic liver disease. [PDF]
Heredia NI +5 more
europepmc +1 more source
Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal. [PDF]
Lens S +11 more
europepmc +1 more source
Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group. [PDF]
Kirk FT +14 more
europepmc +1 more source
Adaptation using IM Adapt of an evidence-based lifestyle intervention to support the management of metabolic-dysfunction associated steatotic liver disease among Hispanic/Latino adults. [PDF]
Heredia NI +5 more
europepmc +1 more source
[Infantile Hepatic Hemangioendothelio- ma with Elevated Alpha-fetoprotein: Case Report and Review]. [PDF]
Valberdi Lecce ML +3 more
europepmc +1 more source
[Adrenal incidentaloma with hyperprocalcitoninemia]. [PDF]
Zambudio-Munuera A +3 more
europepmc +1 more source
Fully robotic pancreatoduodenectomy. First procedure in Mexico
A. Cuendis-Velázquez +6 more
doaj +1 more source

